Guillaume Mestrallet's Avatar

Guillaume Mestrallet

@gmestrallet.bsky.social

Researcher in Immuno-oncology

18 Followers  |  38 Following  |  4 Posts  |  Joined: 28.01.2025  |  1.1781

Latest posts by gmestrallet.bsky.social on Bluesky

Preview
Targeting neoantigens conserved across organs and species overcomes tumor immune escape Neoantigen-targeted immunotherapies hold promise for cancer treatment, but current personalized approaches are time-consuming and costly. Here, we identify neoantigens encoded by Ptprs and Igf2r that ...

We're excited to share our latest work: "Targeting neoantigens conserved across organs and species overcomes tumor immune escape"!

Thanks to the team at @sinaiimmuno.bsky.social !
www.biorxiv.org/content/10.1...

29.09.2025 12:24 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

@francoisrousset.bsky.social will give a talk at Mount Sinai Hospital on May 7th. If interested, please do not hesitate to reach out!

15.04.2025 16:52 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@sinaiimmuno.bsky.social

18.02.2025 15:48 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Glad to share our work about resistance to immunotherapy! We discovered a combination therapy allowing to eliminate 100% of MMRd CRC tumors and >70% or MMRp CRC tumors. We also identified the T cell and macrophage subsets mediating the response. Thanks to the team! www.biorxiv.org/content/10.1...

18.02.2025 15:45 β€” πŸ‘ 8    πŸ” 5    πŸ’¬ 1    πŸ“Œ 0

@gmestrallet is following 20 prominent accounts